| Ticker Symbol: | COV |
|---|---|
| Exchange: | NYSE |
| Contact Info: | 131 Front Street Hamilton HM 12 441 298-2480 |
| CEO/President: | Richard J. Meelia |
| Industry: | Medical - Dental Suppliers / Standard Industry Code: 3841 |
| Description: | Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines, including Surgical Devices, Energy-Based Devices, Respiratory and Monitoring Solutions, Patient Care and Safety Products, Imaging Solutions, Pharmaceutical Products, Medical Supplies and Retail Products. |
| Shares Outstanding: | 499,570 (000) | Market Value: | 23,906,090 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 86.04% | Number of Inst.Shareholders: | 0.82% |
| Last Quarter Sales: | 2595.00 ($Mil.) | Last Quarter Net Income: | 269.00 ($Mil.) |
| Last Quarter EPS: | 0.72 | P/E Ratio: | 18 |
| Most Recent Earnings: | 0.72 on 08/05/08 | Earnings Per Share: | 1.96 |
| Most Recent Split: | Annual Dividend Rate: | .64 | |
| Most Recent Dividend: | Annual Dividend Yield: | 1.34% |


| COVIDIEN LTD | -0.30 | 43.74 | |
| ADVANCED MED OP | -64.40 | 6.59 | |
| BECTON DICKINSO | -20.10 | 70.41 | |
| PATTERSON COMPA | -36.80 | 24.85 | |
| DENTSPLY INTL I | -31.50 | 31.14 |
